CROXILEX ES 600 MG/42.9 MG ORAL SUSPENSION DRY POWDER FOR PREPARATION (150 ML) – 2026 Price Turkey

by

Clinical Data Review: Comprehensive profile for CROXILEX ES 600 MG/42.9 MG ORAL SUSPENSION DRY POWDER FOR PREPARATION (150 ML), including its pharmacological composition, pricing in Turkey (2026), and regulatory status for international patients.

1. Pharmaceutical Profile

Proprietary Name: CROXILEX ES 600 MG/42.9 MG ORAL SUSPENSION DRY POWDER FOR PREPARATION (150 ML)

Manufacturer: MENARINI HEALTH AND PHARMACEUTICAL INDUSTRY TRADE INC.

Registration Status: Licensed by T.C. Ministry of Health

Active Pharmaceutical Ingredient

KLAVULANIK ASIT
AMOKSISILIN 🔗

*Click to view bioequivalent formulations.

2. Therapeutic Indications

CROXILEX ES 600 MG/42.9 MG ORAL SUSPENSION DRY POWDER FOR PREPARATION (150 ML) is formulated with KLAVULANIK ASIT
AMOKSISILIN, a clinically established agent in medical practice.

  • Mechanism of Action: KLAVULANIK ASIT
    AMOKSISILIN acts according to the pharmacological principles of its drug class to provide therapeutic relief.
  • Primary Use: Prescribed by healthcare professionals for conditions responsive to KLAVULANIK ASIT
    AMOKSISILIN     therapy.
  • Dosage Regimen: Please refer to the official Patient Information Leaflet (PIL) included in the packaging for specific dosing instructions relative to age and severity of symptoms.

3. Market Data & Pricing (2026)

Note: Drug prices in Turkey are regulated under the Reference Pricing System (SUT) enforced by the government.

Product Name CROXILEX ES 600 MG/42.9 MG ORAL SUSPENSION DRY POWDER FOR PREPARATION (150 ML)
Barcode (GTIN) 8699508280353
Generic Name KLAVULANIK ASIT
AMOKSISILIN
License Holder MENARINI HEALTH AND PHARMACEUTICAL INDUSTRY TRADE INC.
Pharmacy Retail Price 373.13 TL
⚠️ Clinical Safety Warning

Do not administer CROXILEX ES 600 MG/42.9 MG ORAL SUSPENSION DRY POWDER FOR PREPARATION (150 ML) if the patient has a known hypersensitivity or allergy to KLAVULANIK ASIT
AMOKSISILIN. Purchase only from authorized pharmacies (Eczane) to ensure supply chain integrity.

Disclaimer: This content is compiled from public pharmaceutical records for informational purposes. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified physician regarding any medical condition.
Data Source: Product label via MENARINI HEALTH AND PHARMACEUTICAL INDUSTRY TRADE INC..

Leave a Comment